Recent Advances in Immunohistochemistry in the Diagnosis of Ovarian Neoplasms

Overview

Journal J Clin Pathol

Specialty Pathology

Date 2000 Jul 13

PMID 10889812

Citations 18

Authors

W G McCluggage

Affiliations

Soon will be listed here.

Abstract

This leader reviews recent advances in immunohistochemistry that are useful in the diagnosis of ovarian neoplasms. These include the value of different anticytokeratin antibodies in the distinction between a primary ovarian adenocarcinoma and a metastatic adenocarcinoma, especially of colorectal origin. These antibodies have also helped to clarify the origin of the peritoneal disease in most cases of pseudomyxoma peritonei. The value of antibodies against so called tumour specific antigens, such as CA125 and HAM56, in determining the ovarian origin of an adenocarcinoma is also reviewed. In recent years, several studies have investigated the value of a variety of monoclonal antibodies in the diagnosis of ovarian sex cord stromal tumours and in the distinction between these neoplasms and their histological mimics. These antibodies include those directed against inhibin, CD99, Mullerian inhibiting substance, relaxin like factor, melan A, and calretinin. Of these, anti-alpha inhibin appears to be of most diagnostic value. It is stressed that these antibodies should always be used as part of a larger panel and not in isolation.

Citing Articles

Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site-a Review.

Bhatt A, Mishra S, Glehen O Indian J Surg Oncol. 2023; 14(Suppl 1):15-29.

PMID: 37359927 PMC: 10284789. DOI: 10.1007/s13193-022-01612-9.

Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary - a review.

Jung D, Almstedt K, Battista M, Seeger A, Jakel J, Brenner W J Ovarian Res. 2023; 16(1):50.

PMID: 36869369 PMC: 9983179. DOI: 10.1186/s13048-023-01125-1.

Chemotherapeutic Effect on Ovarian Stroma and Tumor Cells Which Make Problem in Diagnosis and Staging of Tumor.

Nasirian N, Elmizadeh K Iran J Pathol. 2021; 16(4):465-466.

PMID: 34567200 PMC: 8463762. DOI: 10.30699/ijp.2021.520513.2540.

Essentials for Pathological Evaluation of Peritoneal Surface Malignancies and Synoptic Reporting of Cytoreductive Surgery Specimens-A review and evidence-based guide.

Bhatt A, Mishra S, Parikh L, Sheth S, Gorur I Indian J Surg Oncol. 2020; 11(1):101-126.

PMID: 32205979 PMC: 7064688. DOI: 10.1007/s13193-019-00897-7.

Clinicopathological Study of Surface Epithelial Tumours of the Ovary: An Institutional Study.

Modepalli N, Venugopal S J Clin Diagn Res. 2016; 10(10):EC01-EC04.

PMID: 27891341 PMC: 5121679. DOI: 10.7860/JCDR/2016/21741.8716.

References

Zheng W, Sung C, Hanna I, Depetris G, Lambert-Messerlian G, Steinhoff M . Alpha and beta subunits of inhibin/activin as sex cord-stromal differentiation markers. Int J Gynecol Pathol. 1997; 16(3):263-71. DOI: 10.1097/00004347-199707000-00012. View

Guerrieri C, Franlund B, Fristedt S, Gillooley J, BOERYD B . Mucinous tumors of the vermiform appendix and ovary, and pseudomyxoma peritonei: histogenetic implications of cytokeratin 7 expression. Hum Pathol. 1997; 28(9):1039-45. DOI: 10.1016/s0046-8177(97)90057-5. View

Younes M, Katikaneni P, Lechago L, Lechago J . HAM56 antibody: a tool in the differential diagnosis between colorectal and gynecological malignancy. Mod Pathol. 1994; 7(3):396-400. View

Baker R, Hildebrandt R, Rouse R, Hendrickson M, Longacre T . Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex-cord-like elements. Hum Pathol. 1999; 30(6):671-9. DOI: 10.1016/s0046-8177(99)90093-x. View

Meunier H, Rivier C, Evans R, Vale W . Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions. Proc Natl Acad Sci U S A. 1988; 85(1):247-51. PMC: 279521. DOI: 10.1073/pnas.85.1.247. View

Ronnett B, Kurman R, Zahn C, Shmookler B, Jablonski K, Kass M . Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol. 1995; 26(5):509-24. DOI: 10.1016/0046-8177(95)90247-3. View

Prayson R, HART W, Petras R . Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol. 1994; 18(6):591-603. View

Costa M, Derose P, Roth L, Brescia R, Zaloudek C, Cohen C . Immunohistochemical phenotype of ovarian granulosa cell tumors: absence of epithelial membrane antigen has diagnostic value. Hum Pathol. 1994; 25(1):60-6. DOI: 10.1016/0046-8177(94)90172-4. View

Loy T, Quesenberry J, Sharp S . Distribution of CA 125 in adenocarcinomas. An immunohistochemical study of 481 cases. Am J Clin Pathol. 1992; 98(2):175-9. DOI: 10.1093/ajcp/98.2.175. View

10.

Ueda G, Sawada M, Ogawa H, TANIZAWA O, Tsujimoto M . Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the ovary. Gynecol Oncol. 1993; 51(2):219-23. DOI: 10.1006/gyno.1993.1276. View

11.

Sheahan K, OBrien M, Burke B, Dervan P, OKeane J, GOTTLIEB L . Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies. Am J Clin Pathol. 1990; 94(2):157-64. DOI: 10.1093/ajcp/94.2.157. View

12.

Cuatrecasas M, Matias-Guiu X, Prat J . Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei. A clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations. Am J Surg Pathol. 1996; 20(6):739-46. DOI: 10.1097/00000478-199606000-00012. View

13.

Young R, Perez-Atayde A, Scully R . Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein. Am J Surg Pathol. 1984; 8(9):709-18. DOI: 10.1097/00000478-198409000-00011. View

14.

Soslow R, Rouse R, Hendrickson M, Silva E, Longacre T . Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis. Int J Gynecol Pathol. 1996; 15(3):257-65. DOI: 10.1097/00004347-199607000-00011. View

15.

Demopoulos R, Sitelman A, Flotte T, BIGELOW B . Ultrastructural study of a female adnexal tumor of probable wolffian origin. Cancer. 1980; 46(10):2273-80. DOI: 10.1002/1097-0142(19801115)46:10<2273::aid-cncr2820461027>3.0.co;2-2. View

16.

Stewart C, Jeffers M, Kennedy A . Diagnostic value of inhibin immunoreactivity in ovarian gonadal stromal tumours and their histological mimics. Histopathology. 1997; 31(1):67-74. DOI: 10.1046/j.1365-2559.1997.5780819.x. View

17.

Busam K, Iversen K, Coplan K, Old L, STOCKERT E, Chen Y . Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. Am J Surg Pathol. 1998; 22(1):57-63. DOI: 10.1097/00000478-199801000-00007. View

18.

Hildebrandt R, Rouse R, Longacre T . Value of inhibin in the identification of granulosa cell tumors of the ovary. Hum Pathol. 1998; 28(12):1387-95. DOI: 10.1016/s0046-8177(97)90229-x. View

19.

Hammad A, Jasnosz K, Olson P . Expression of alpha-fetoprotein by ovarian Sertoli-Leydig cell tumors. Case report and review of the literature. Arch Pathol Lab Med. 1995; 119(11):1075-9. View

20.

Matias-Guiu X, Pons C, Prat J . Müllerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Hum Pathol. 1998; 29(8):840-5. DOI: 10.1016/s0046-8177(98)90454-3. View